Literature DB >> 16864810

Tetanus vaccination and risk of multiple sclerosis: a systematic review.

Miguel A Hernán1, Alvaro Alonso, Sonia Hernández-Díaz.   

Abstract

OBJECTIVE: To conduct a systematic review on the association between tetanus vaccination and the risk of multiple sclerosis (MS).
METHODS: The authors searched the databases Medline, LILACS, EMBASE, and Science Citation Index including the period 1966 to September 1, 2005. Eligible studies had to meet the following inclusion criteria: presentation of original data, case-control or cohort design, physician-confirmed diagnosis of MS as the outcome of interest, attempt to ascertain vaccinations in a period before the diagnosis, and report of an association measure between tetanus vaccination and incidence of MS, and its 95% CI or enough information to compute it. Study specific log ORs were weighted by the inverse of their variances to obtain a pooled estimate and its 95% CI.
RESULTS: The OR of MS associated with history of tetanus vaccination was 0.67 (95% CI: 0.55 to 0.81). There was little indication of heterogeneity of results across studies.
CONCLUSION: Tetanus vaccination is associated with a lower risk of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864810     DOI: 10.1212/01.wnl.0000225079.51201.f9

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Vaccination against infection in patients with multiple sclerosis.

Authors:  Micha Loebermann; Alexander Winkelmann; Hans-Peter Hartung; Hartmut Hengel; Emil C Reisinger; Uwe K Zettl
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

Review 2.  [Vaccination and multiple sclerosis].

Authors:  M Löbermann; A Winkelmann; E C Reisinger; U K Zettl
Journal:  Nervenarzt       Date:  2010-02       Impact factor: 1.214

Review 3.  Immunizations and risk of multiple sclerosis: systematic review and meta-analysis.

Authors:  Mauricio F Farez; Jorge Correale
Journal:  J Neurol       Date:  2011-03-24       Impact factor: 4.849

Review 4.  Vaccines in Multiple Sclerosis.

Authors:  Eric M L Williamson; Salim Chahin; Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 5.  Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?

Authors:  Shani Witman Tsur; Eli Adrian Zaher; Meydan Tsur; Karolina Kania; Alicja Kalinowska-Łyszczarz
Journal:  Int J Mol Sci       Date:  2021-04-08       Impact factor: 5.923

Review 6.  Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.

Authors:  Celia Oreja-Guevara; Heinz Wiendl; Bernd C Kieseier; Laura Airas
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

7.  Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.

Authors:  J Massa; K L Munger; E J O'Reilly; L I Levin; A Ascherio
Journal:  J Neuroimmunol       Date:  2009-02-07       Impact factor: 3.478

Review 8.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

Review 9.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 10.  Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective.

Authors:  Dejan Jakimovski; Bianca Weinstock-Guttman; Murali Ramanathan; Michael G Dwyer; Robert Zivadinov
Journal:  Vaccines (Basel)       Date:  2020-01-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.